Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 248 of 640

Advanced search

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT07368608: A Study of BEBT-701 in Patients With Mild to Moderate Hypertension and Elevated Low-Density Lipoprotein Cholesterol（LDL-C）

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT07235150: A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT07221669: A Study to Learn About Salanersen's (BIIB115) Effects on Movement and Its Safety When Given Before Symptoms Appear in Babies With Genetically Diagnosed Spinal Muscular Atrophy (SMA)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT07182149: A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT07153796: A Phase 1b/2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Combination With Low Intensity Chemotherapy in Older Patients With Newly Diagnosed B-Cell Acute Lymphoblastic Leukemia

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT07050186: Cemiplimab for the Treatment of Incurable Metastatic or Unresectable NUT Carcinoma

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT07013487: A Study to Evaluate V181 Dengue Vaccine in Healthy Participants 2 to 17 Years of Age (V181-005/MOBILIZE-1)

Study type: INTERVENTIONAL. Phase: PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT06993506: Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT06991556: An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT06909344: 577-nm Diode Laser in the Treatment of Non -Inflammatory Acne

Study type: INTERVENTIONAL. Phase: NA.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT06822543: A Single Arm, Phase 2 Study of Datopotamab Deruxtecan, Carboplatin, and Pembrolizumab for Treatment-naive Brain Metastases From NSCLC (Non-small Cell Lung Cancer)

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT06717178: Cancer and Aging Research Group (CARG) Chemotherapy Toxicity Risk Scores in Older Adults With Cancer in China

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT06427798: Somatostatin-Receptors (SSTR)-Agonist [212Pb]VMT-alpha-NET in Metastatic or Inoperable SSTR+ Gastrointestinal Neuroendocrine Tumor and Pheochromocytoma/Paraganglioma Previously Treated With Systemic Targeted Radioligand Therapy

Study type: INTERVENTIONAL. Phase: PHASE1, PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT06412666: A Study to Evaluate the Effect of Aficamten in Pediatric Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM).

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT06218303: Prototype DAA/TAA Vaccine Targeting MUC1 for Immune Interception and Prevention in Ductal Carcinoma In Situ

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT06070649: The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT05719441: A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT05621668: A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT05419037: Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With Lipodystrophy

Study type: OBSERVATIONAL. Phase: .

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT05143177: A Study to Evaluate the Efficacy and Safety of DA-1229 (Evogliptin) in Patient's Calcific Aortic Valve Disease With Mild to Moderate Aortic Stenosis (EVOID-AS)

Study type: INTERVENTIONAL. Phase: PHASE2, PHASE3.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT04928508: Advanced or Recurrent Solid Tumors Treated With SHetA2

Study type: INTERVENTIONAL. Phase: PHASE1.

ClinicalTrials.govOriginal source

🇺🇸Aug 18Researchclinicaltrials.govTier 1 · Trial registry

NCT02210078: Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection

Study type: INTERVENTIONAL. Phase: PHASE2.

ClinicalTrials.govOriginal source

🌍Aug 18discoverynews.google.comTier 2 · Trade media

Building Resilience for the Future of Biopharma Innovation

Fierce BiotechOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical files Korea phase 3 for biweekly GLP-1 obesity drug - CHOSUNBIZ

ChosunbizOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical files IND for biweekly obesity drug bofanglutide in Phase 3 trial

헤럴드경제Original source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

JW Pharmaceutical Submits IND for Phase 3 Trial of Biweekly Obesity Treatment

아시아경제Original source

🇺🇰Aug 18Regulatoryabpi.org.ukTier 1 · Regulatory source

The NHS Federated Data Platform, the Single Patient Record and the Health Data Research Service – what are they, and how do they relate to the UK’s pharmaceutical industry?

ABPI UKOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

EyePoint Reports Topline Results from LUGANO Phase 3 Trial for DURAVYU in Wet AMD

Kalkine MediaOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

How Pharmaceutical Companies Are Expanding Patient Access to Unapproved Treatments

Big Easy MagazineOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Before Mundhe, they took on food and drug giants

Mumbai MirrorOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Eyepoint study results for vision treatment disappoint, but Watertown-based company still sees promise

The Boston GlobeOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Amylyx stock rises on Phase 3 trial results date

Investing.comOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Peptide Therapy: Uses, Types & What's FDA-Approved

Haute LivingOriginal source

🌍Aug 18discoverynews.google.comTier 2 · Trade media

US FDA Drug Inspections Return To Pre-Pandemic Levels; Domestic OIA Citations Exceed Global Average

insights.citeline.comOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Frank Mazzola of Real Chemistry Identifies Gap Between Pharmaceutical Innovation and Public Perception

geneonline.comOriginal source

🇺🇸Aug 18Researchatlasventure.comTier 2 · Direct publisher

Make US INDs Great Again

Atlas VentureOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Big pharma shifts chronic treatments to pills as South Korea readies launches - CHOSUNBIZ

ChosunbizOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Top biotech picks combining analyst conviction and fair value upside

Investing.comOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Psychedelic: Definium’s LSD-based pill meets endpoints in GAD study

TipRanksOriginal source

🇺🇸Aug 18Devicesinvestors.bd.comTier 1 · Company source

BD Appoints Gary Sorsher as Chief Quality Officer; Jeff Silvestri to Retire

Becton Dickinson (BD)Original source

🇺🇸Aug 18universitynews.mit.eduTier 2 · Direct publisher

DNA shaper steers nervous system development

MIT Biology NewsOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group

Business WireOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Amylyx to announce phase 3 trial results for hypoglycemia drug

Investing.comOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Wired For Care

UC San Diego TodayOriginal source

🌍Aug 18discoverynews.google.comTier 2 · Trade media

EyePoint shares plummet after phase 3 stumble for AMD drug-device combo Duravyu

Fierce PharmaOriginal source

🌍Aug 18discoverynews.google.comTier 2 · Trade media

Sanofi to lay off 229 workers in Mass., a year after $9.1B Blueprint Medicines acquisition

statnews.comOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

FDA Moves to End Voluntary GRAS System for Food Ingredients

MyChesCoOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Biotech Asks 1st Circ. To Undo Red Cross Antitrust Immunity

Law360Original source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

FDA issues draft guidance on assessing container and closure systems for drugs and biologics

RAPSOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

The Peptide Gold Rush Wants a License: Washington Opens a Third Lane Between Pharma and the Gray Market

trialsitenews.comOriginal source

🇨🇭Aug 18CROpsi-cro.comTier 2 · Direct publisher

PSI CRO at SCOPE Europe 2026: Eliminating Blind Spots in Site Selection with an AI Knowledge Platform

PSI CROOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Henlius and Sandoz Strike Collaboration Agreement | PharmExec

Pharmaceutical ExecutiveOriginal source

🌍Aug 18Researchanswers.childrenshospital.orgTier 2 · Direct publisher

العثور على إجابات ورعاية لاضطراب حركي نادر: تجربة Aisha مع التحفيز العميق للدماغ

Boston Children's HospitalOriginal source

🌍Aug 18discoverynews.google.comTier 2 · Trade media

Eyepoint study results for vision treatment disappoint, but company still sees promise

statnews.comOriginal source

🇺🇸Aug 18universitynews.mit.eduTier 2 · Direct publisher

Mathematical framework connects biological principles to manufacturable, adaptive materials

MIT Biology NewsOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Former U.S. Public Health Service officer and medication safety leader named MUSC pharmacy dean

education.musc.eduOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Pharmaceutical Stocks To Add to Your Watchlist - August 17th

MarketBeatOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Scan & complain: Karnataka FDA launches QR code system for food, drug grievances

The Times of IndiaOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Argenx Stock Is Having Its Best Day Ever. The Biotech’s Biggest Drug Could Get Even Bigger.

Barron'sOriginal source

🌍Aug 18discoverynews.google.comTier 3 · Aggregated media

Faller Packaging Acquires Paperpack To Expand Pharmaceutical Packaging Platform Across South-Eastern Europe

Pulse 2.0Original source